The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
The Invisible Cancer Podcast raises awareness of neuroendocrine cancer, a cancer most people have never heard of, and this lack of awareness can affect diagnosis, treatment, and care. Through real-life stories, expert insights, and practical advice, we explore the challenges patients face, from initial diagnosis to management, including the impact on mental health and ongoing follow-up.
Hosted by Lisa Walker and produced by Neuroendocrine Cancer UK, this podcast shines a light on neuroendocrine and other often-overlooked cancers, offering information, support, and connection to anyone affected.
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
Life After Diagnosis: Navigating Work, Pregnancy, and Motherhood with Neuroendocrine Cancer
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this insightful podcast episode, Catherine Bouvier, CEO of Neuroendocrine Cancer UK, engages in a heartwarming conversation with Rachael, a resilient mother who navigated the challenges of work, pregnancy, and motherhood following a diagnosis of neuroendocrine cancer at the young age of 32.
Rachael shares her journey, which began shortly after moving into a new home with her fiancé, as she dealt with persisting symptoms eventually diagnosed as small bowel neuroendocrine tumours. Despite the diagnosis, Rachael's story takes a hopeful turn following successful treatment and her wedding to her supportive partner.
Wanting to start a family, Rachael faced tough decisions regarding the feasibility and ethics of pregnancy post-treatment. Through open communication with her medical team and thoughtful consideration, Rachael and her husband welcomed their first child.
Rachael candidly reflects on the realities of being a full-time working mother, sharing insights on pregnancy, and joyfully reveals her anticipation of welcoming a second child.
If this story touches you and you're facing challenges such as infertility due to cancer, please know that we are here to support you.
Further Support: